@article{3088353,
    title = "Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group",
    author = "Kalpadakis, C. and Pangalis, G.A. and Angelopoulou, M.K. and Sachanas, S. and Kontopidou, F. and Moschogiannis, M. and Ximeri, M. and Tsirkinidis, P. and Yiakoumis, X. and Papadaki, H.A. and Vassilakopoulos, T.P.",
    journal = "Clinical Lymphoma Myeloma and Leukemia",
    year = "2014",
    volume = "55",
    number = "11",
    pages = "2640-2642",
    publisher = "Informa Healthcare",
    doi = "10.3109/10428194.2014.897703",
    keywords = "hemoglobin;  lactate dehydrogenase;  rituximab;  hemoglobin;  lactate dehydrogenase, adult;  aged;  anemia;  cancer survival;  female;  hemoglobin blood level;  high risk population;  human;  intermethod comparison;  large cell lymphoma;  Letter;  lymphadenopathy;  major clinical study;  male;  middle aged;  named inventories, questionnaires and rating scales;  splenic marginal zone lymphoma;  Splenic Marginal Zone Lymphoma Working Group;  thrombocyte count;  thrombocytopenia;  validation study;  lymphatic system disease;  marginal zone lymphoma;  metabolism;  organization and management;  pathology;  prognosis;  reproducibility;  severity of illness index;  spleen tumor;  standards;  survival;  very elderly, Adult;  Aged;  Aged, 80 and over;  Female;  Hemoglobins;  Humans;  L-Lactate Dehydrogenase;  Lymphatic Diseases;  Lymphoma, B-Cell, Marginal Zone;  Male;  Middle Aged;  Pathology, Clinical;  Platelet Count;  Prognosis;  Reproducibility of Results;  Severity of Illness Index;  Splenic Neoplasms;  Survival Analysis"
}